230 related articles for article (PubMed ID: 11444639)
21. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
Ottani F; Ferrini D; Di Pasquale G; Galvani M
Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
[TBL] [Abstract][Full Text] [Related]
22. Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Montalescot G; Bal-dit-Sollier C; Chibedi D; Collet JP; Soulat T; Dalby M; Choussat R; Cohen A; Slama M; Steg PG; Dubois-Randé JL; Metzger JP; Tarragano F; Guermonprez JL; Drouet L;
Am J Cardiol; 2003 Apr; 91(8):925-30. PubMed ID: 12686329
[TBL] [Abstract][Full Text] [Related]
23. Heparin versus placebo for non-ST elevation acute coronary syndromes.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Magee K
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD003462. PubMed ID: 24972265
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
25. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.
Klein W; Buchwald A; Hillis WS; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
Am J Cardiol; 1997 Sep; 80(5A):30E-34E. PubMed ID: 9296467
[TBL] [Abstract][Full Text] [Related]
26. Low molecular weight heparins and coronary artery disease.
Zed PJ
Curr Cardiol Rep; 2000 Jan; 2(1):61-8. PubMed ID: 10980874
[TBL] [Abstract][Full Text] [Related]
27. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
Fox KA; Antman EM; Cohen M; Bigonzi F;
Am J Cardiol; 2002 Sep; 90(5):477-82. PubMed ID: 12208405
[TBL] [Abstract][Full Text] [Related]
28. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group.
Swahn E; Wallentin L
Am J Cardiol; 1997 Sep; 80(5A):25E-29E. PubMed ID: 9296466
[TBL] [Abstract][Full Text] [Related]
29. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].
Husted SE; Nielsen HK
Ugeskr Laeger; 2010 Oct; 172(42):2888-91. PubMed ID: 21040659
[TBL] [Abstract][Full Text] [Related]
30. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
Turpie AG
Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029
[TBL] [Abstract][Full Text] [Related]
31. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
Wong GC; Giugliano RP; Antman EM
JAMA; 2003 Jan; 289(3):331-42. PubMed ID: 12525234
[TBL] [Abstract][Full Text] [Related]
32. Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
Rubboli A; Ottani F; Capecchi A; Brancaleoni R; Galvani M; Swahn E
Cardiology; 2007; 107(2):132-9. PubMed ID: 16864962
[TBL] [Abstract][Full Text] [Related]
33. Low-molecular-weight heparin as a bridge to timely revascularization in unstable coronary artery disease -- an update of the Fragmin during Instability in Coronary Artery Disease II Trial.
Wallentin L
Haemostasis; 2000; 30 Suppl 2():108-13; discussion 106-7. PubMed ID: 11251353
[TBL] [Abstract][Full Text] [Related]
34. Low molecular weight heparins in the management of unstable angina/non-Q-wave myocardial infarction.
Cohen M
Semin Thromb Hemost; 1999; 25 Suppl 3():113-21. PubMed ID: 10549726
[TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparins for acute coronary syndromes.
Spinler SA; Nawarskas JJ
Ann Pharmacother; 1998 Jan; 32(1):103-10. PubMed ID: 9475828
[TBL] [Abstract][Full Text] [Related]
36. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.
Antman EM
Am Heart J; 1998 Jun; 135(6 Pt 3 Su):S353-60. PubMed ID: 9628449
[TBL] [Abstract][Full Text] [Related]
37. [Low molecular weight heparin in unstable angina].
Kher A; Samama MM
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1495-500. PubMed ID: 9092409
[TBL] [Abstract][Full Text] [Related]
38. Acute management--how should we intervene?
Kontny F
Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I8-12. PubMed ID: 10680038
[TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight heparins in acute unstable coronary artery disease - an update.
Turpie AG
Haemostasis; 1999 Dec; 29 Suppl S1():72-5. PubMed ID: 10629408
[TBL] [Abstract][Full Text] [Related]
40. The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study.
Wallentin L; Dellborg DM; Lindahl B; Nilsson T; Pehrsson K; Swahn E
Clin Cardiol; 2001 Mar; 24(3 Suppl):I12-4. PubMed ID: 11286309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
